86 related articles for article (PubMed ID: 27492193)
1. Anti-inflammatory properties of pterocarpanquinone LQB-118 in mice.
Riça IG; Netto CD; Rennó MN; Abreu PA; Costa PRR; da Silva AJM; Cavalcante MCM
Bioorg Med Chem; 2016 Sep; 24(18):4415-4423. PubMed ID: 27492193
[TBL] [Abstract][Full Text] [Related]
2. The pterocarpanquinone LQB 118 inhibits inflammation triggered by zymosan in vivo and in vitro.
Lima ÉA; Cavalcante-Silva LHA; Carvalho DCM; Netto CD; Costa PRR; Rodrigues-Mascarenhas S
Int Immunopharmacol; 2020 Jun; 83():106399. PubMed ID: 32193104
[TBL] [Abstract][Full Text] [Related]
3. The orally active pterocarpanquinone LQB-118 exhibits cytotoxicity in prostate cancer cell and tumor models through cellular redox stress.
Martino T; Kudrolli TA; Kumar B; Salviano I; Mencalha A; Coelho MGP; Justo G; Costa PRR; Sabino KCC; Lupold SE
Prostate; 2018 Feb; 78(2):140-151. PubMed ID: 29105806
[TBL] [Abstract][Full Text] [Related]
4. Preparative chiral separation and absolute configuration of the synthetic pterocarpanquinone LQB-118.
Scatena GS; Cassiano NM; Netto CD; Costa PRR; Cass QB; Batista JM
Chirality; 2017 May; 29(5):167-171. PubMed ID: 28403568
[TBL] [Abstract][Full Text] [Related]
5. NFκB pathway and microRNA-9 and -21 are involved in sensitivity to the pterocarpanquinone LQB-118 in different CML cell lines.
de Faria FC; Leal ME; Bernardo PS; Costa PR; Maia RC
Anticancer Agents Med Chem; 2015; 15(3):345-52. PubMed ID: 25964959
[TBL] [Abstract][Full Text] [Related]
6. The pterocarpanquinone LQB-118 inhibits tumor cell proliferation by downregulation of c-Myc and cyclins D1 and B1 mRNA and upregulation of p21 cell cycle inhibitor expression.
Martino T; Magalhães FC; Justo GA; Coelho MG; Netto CD; Costa PR; Sabino KC
Bioorg Med Chem; 2014 Jun; 22(12):3115-22. PubMed ID: 24794748
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antineoplastic and immunological effects of pterocarpanquinone LQB-118.
Salustiano EJ; Dumas ML; Silva-Santos GG; Netto CD; Costa PR; Rumjanek VM
Invest New Drugs; 2016 Oct; 34(5):541-51. PubMed ID: 27189479
[TBL] [Abstract][Full Text] [Related]
8. The therapeutical potential of a novel pterocarpanquinone LQB-118 to target inhibitor of apoptosis proteins in acute myeloid leukemia cells.
de Souza Reis FR; de Faria FC; Castro CP; de Souza PS; da Cunha Vasconcelos F; Bello RD; da Silva AJ; Costa PR; Maia RC
Anticancer Agents Med Chem; 2013 Feb; 13(2):341-51. PubMed ID: 22721384
[TBL] [Abstract][Full Text] [Related]
9. LQB-118, a pterocarpanquinone structurally related to lapachol [2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone]: a novel class of agent with high apoptotic effect in chronic myeloid leukemia cells.
Maia RC; Vasconcelos FC; de Sá Bacelar T; Salustiano EJ; da Silva LF; Pereira DL; Moellman-Coelho A; Netto CD; da Silva AJ; Rumjanek VM; Costa PR
Invest New Drugs; 2011 Dec; 29(6):1143-55. PubMed ID: 20499132
[TBL] [Abstract][Full Text] [Related]
10. LQB-118, an orally active pterocarpanquinone, induces selective oxidative stress and apoptosis in Leishmania amazonensis.
Ribeiro GA; Cunha-Júnior EF; Pinheiro RO; da-Silva SA; Canto-Cavalheiro MM; da Silva AJ; Costa PR; Netto CD; Melo RC; Almeida-Amaral EE; Torres-Santos EC
J Antimicrob Chemother; 2013 Apr; 68(4):789-99. PubMed ID: 23288404
[TBL] [Abstract][Full Text] [Related]
11. Preclinical Studies Evaluating Subacute Toxicity and Therapeutic Efficacy of LQB-118 in Experimental Visceral Leishmaniasis.
Cunha-Júnior EF; Martins TM; Canto-Cavalheiro MM; Marques PR; Portari EA; Coelho MG; Netto CD; Costa PR; Sabino KC; Torres-Santos EC
Antimicrob Agents Chemother; 2016 Jun; 60(6):3794-801. PubMed ID: 27067332
[TBL] [Abstract][Full Text] [Related]
12. Insights into the Biological Evaluation of Pterocarpanquinones and Carbapterocarpans with Anti-tumor Activity against MDR Leukemias.
Rumjanek VM; Maia RC; Salustiano EJ; Costa PRR
Anticancer Agents Med Chem; 2019; 19(1):29-37. PubMed ID: 29692266
[TBL] [Abstract][Full Text] [Related]
13. Baicalin attenuates inflammation by inhibiting NF-kappaB activation in cigarette smoke induced inflammatory models.
Lixuan Z; Jingcheng D; Wenqin Y; Jianhua H; Baojun L; Xiaotao F
Pulm Pharmacol Ther; 2010 Oct; 23(5):411-9. PubMed ID: 20566376
[TBL] [Abstract][Full Text] [Related]
14. Shikonin exerts anti-inflammatory effects in a murine model of lipopolysaccharide-induced acute lung injury by inhibiting the nuclear factor-kappaB signaling pathway.
Liang D; Sun Y; Shen Y; Li F; Song X; Zhou E; Zhao F; Liu Z; Fu Y; Guo M; Zhang N; Yang Z; Cao Y
Int Immunopharmacol; 2013 Aug; 16(4):475-80. PubMed ID: 23651796
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of the local or oral delivery of the novel naphthopterocarpanquinone LQB-118 against cutaneous leishmaniasis.
da Cunha-Júnior EF; Pacienza-Lima W; Ribeiro GA; Netto CD; do Canto-Cavalheiro MM; da Silva AJ; Costa PR; Rossi-Bergmann B; Torres-Santos EC
J Antimicrob Chemother; 2011 Jul; 66(7):1555-9. PubMed ID: 21531758
[TBL] [Abstract][Full Text] [Related]
16. The pterocarpanquinone LQB 118 induces apoptosis in tumor cells through the intrinsic pathway and the endoplasmic reticulum stress pathway.
de Sá Bacelar T; da Silva AJ; Costa PR; Rumjanek VM
Anticancer Drugs; 2013 Jan; 24(1):73-83. PubMed ID: 22960938
[TBL] [Abstract][Full Text] [Related]
17. Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice.
Zhong WT; Wu YC; Xie XX; Zhou X; Wei MM; Soromou LW; Ci XX; Wang DC
Fitoterapia; 2013 Oct; 90():132-9. PubMed ID: 23751215
[TBL] [Abstract][Full Text] [Related]
18. DXXK exerts anti-inflammatory effects by inhibiting the lipopolysaccharide-induced NF-κB/COX-2 signalling pathway and the expression of inflammatory mediators.
Yu Y; Li X; Qu L; Chen Y; Dai Y; Wang M; Zou W
J Ethnopharmacol; 2016 Feb; 178():199-208. PubMed ID: 26571085
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of Mahaenggamseok-tang on neutrophilic lung inflammation is associated with NF-κB suppression and Nrf2 activation.
Kim KH; Lee JY; Kwun MJ; Choi JY; Han CW; Ha KT; Jeong SI; Jeong HS; Joo M
J Ethnopharmacol; 2016 Nov; 192():486-495. PubMed ID: 27660010
[TBL] [Abstract][Full Text] [Related]
20. Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-κB inhibition.
Oh SW; Cha JY; Jung JE; Chang BC; Kwon HJ; Lee BR; Kim DY
J Ethnopharmacol; 2011 Jul; 136(3):414-21. PubMed ID: 20643202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
